Frontlight ResearchEarly access
Trial site
John Theurer Cancer Center At Hackensack UMC
- 12running trials
- 5closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Acute myeloid leukaemia4 trials
- Multiple myeloma3 trials
- Colorectal cancer2 trials
- Triple-negative breast cancer2 trials
- Cervical cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Hodgkin lymphoma1 trial
- and 5 more
- Phase
- Phase 27 trials
- Phase 1/25 trials
- Phase 13 trials
- Phase 32 trials
- Status
- Recruiting6 trials
- Active, not recruiting5 trials
- Completed3 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Daiichi Sankyo2 trials
- Ariceum Therapeutics GmbH1 trial
- Arog Pharmaceuticals, Inc.1 trial
- BioNTech SE1 trial
- Bristol-Myers Squibb1 trial
- and 11 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Acute myeloid leukaemia1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )
Completed
Terminated
Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026